ARCHIVES

NCI begins rewrite of cancer center grant guidelines; will allow clinical investigator support. Goal is to implement P30-P50 working group recommendations, simplify guidelines, Karen Antman tells advisory board.

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | March 19, 2004

Download PDF Visit The Full Archive

Related Articles

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Obituaries: Fritz Bach, 77, and William Wolff, 94

September 9, 2011

With NIH “Accountability” As Background, Advocates Support Budget Increases.

March 30, 2001

Non-Invasive Test May Detect Lung Cancer In Early Stages

September 26, 2003

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005